337 Results (Page 1 of 14)
Singapore Markets Research Reports
Singapore Kidney Cancer Therapeutics Market Analysis
The Singapore Kidney Cancer Therapeutics Market was valued at $7.5 Mn in 2023 and is predicted to grow at a CAGR of 5.46% from 2023 to 2030, to $11 Mn by 2030. Singapore Kidney Cancer Therapeutics Market is growing due to the Increasing Prevalence of Renal Cell Carcinoma, Demand for Immunotherapies, and Technological advancements. The industry is primarily dominated by players such as Merck, Pfizer Inc (U.S.), AstraZeneca (U.K.), Bristol-Myers Squibb Company (U.S.), Dr. Reddy's Laboratories Ltd (India), Sun Pharmaceutical Industries Ltd (India) and Novartis AG (Switzerland).
Singapore Dental Consumables Market Analysis
The Singapore Dental Consumables Market was valued at $40.6 Mn in 2023 and is projected to grow at a CAGR of 8.6% from 2023 to 2023, to $72.3 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, and changing living standards. The industry is primarily dominated by players such as Dentsply Sirona, Danaher, Align Technology, Planmeca, 3M, Carestream Dental among others.
Singapore Dental Caries Detectors Market Analysis
The Singapore Dental Caries Detectors Market was valued at $0.3 Mn in 2023 and is predicted to grow at a CAGR of 9.5% from 2023 to 2030, to $0.5 Mn by 2030. Singapore Dental Caries Detectors Market is growing due to Increasing Dental Awareness and Education, Prevalence of dental caries, and Technological Advancements. The market is primarily dominated by players such as Sirona Dental Systems, Dentsply Sirona, KaVo Kerr, Ivoclar Vivadent, Softdent, FONA Dental, Genoray International Co, I.N. Dentaland and Planmeca.
Singapore Exosome Research Market Analysis
The Singapore Exosome Research Market was valued at $0.2 Mn in 2023 and is projected to grow at a CAGR of 16.6% from 2023 to 2023, to $0.6 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, increasing advanced applications of exosomes. The industry is primarily dominated by players such as Allozymes, Albatroz, Hitachi Chemical Diagnostics Inc., Qiagen, Gero, Lonza Group Ltd among others.
Singapore Clinical Nutrition for Diabetes Care Market Analysis
The Singapore Clinical Nutrition for Diabetes Care Market was valued at $2.58 Mn in 2023 and is predicted to grow at a CAGR of 5.38% from 2023 to 2030, to $3.72 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Nutribio, Pfizer Inc., and Novo Nordisk among others.
Singapore Pharmacy Automation Device Market Analysis
The Singapore Pharmacy Automation Device Market was valued at $6.6 Mn in 2023 and is predicted to grow at a CAGR of 10.5% from 2023 to 2030, to $13.3 Mn by 2030. Singapore Pharmacy Automation Device Market is growing due to Demand for Efficiency, Rising Demand for Pharmaceuticals, and end-user adoption. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter; Talyst, LLC, Scriptpro LLC.
Singapore Cardiac Pacemakers Market Analysis
The Singapore Cardiac Pacemakers Market was valued at $4.86 Mn in 2023 and is predicted to grow at a CAGR of 3.8% from 2023 to 2030, to $6.31 Mn by 2030. The key drivers of this industry include increasing prevalence, healthcare expenditure, and a rising aging population. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Singapore Clinical Nutrition for Cancer Care Market Analysis
The Singapore Clinical Nutrition for Cancer Care Market was valued at $6.8 Mn in 2023 and is predicted to grow at a CAGR of 5.64% from 2023 to 2030, to $9.9 Mn by 2030. The key drivers of the market include the increasing prevalence of cancer, improved healthcare infrastructure, and rising disposable incomes. The prominent players of the Singapore Clinical Nutrition for Cancer Care Market are Nestlé Health Science, Abbott Nutrition, B. Braun Melsungen AG, and Fresenius Kabi, among others.
Singapore Gram-Negative Infection Therapeutics Market Analysis
The Singapore Gram-Negative Infection Therapeutics Market was valued at $17.8 Mn in 2023 and is predicted to grow at a CAGR of 6.5% from 2023 to 2030 to $27.7 Mn by 2030. Factors driving this expansion include increasing prevalence, rising demand for effective treatments, and an aging population. Major companies in this market include Novartis, Merck, Roche, and others.
Singapore Home Infusion Therapy Market
The Singapore Home Infusion Therapy Market was valued at $43.2 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $77.4 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Singapore Home Infusion Therapy Market are Terumo Corporation, Nipro Corporation, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Singapore Hepatitis A Therapeutics Market Analysis
The Singapore Hepatitis A Therapeutics Market was valued at $0.88 Mn in 2023 and is predicted to grow at a CAGR of 2.8% from 2023 to 2030 to $1.07 Mn by 2030. Key drivers of this growth include advancements in vaccines, shifting epidemiology, and travel-related Hepatitis A cases in Singapore. Major players in this market segment include Takeda and F. Hoffmann-La Roche Ltd., among others.
Singapore Nutritional Supplements Market Analysis
By 2030, it is anticipated that the Singapore Nutrition and Supplements market will reach a value of $0.8 Bn from $0.5 Bn in 2022, growing at a CAGR of 6.9% during 2022-2030. The market is primarily dominated by local players such as Eu Yan Sang International, Bio-Life Science Group, and Blackmores. The market for nutrition and supplements in Singapore is primarily driven by government initiatives and increasing consumer awareness of health and lifestyle. The Singapore nutrition and supplements market in Singapore is segmented by Type, Product, application, and Distribution Channel.
Singapore Growth Hormone Deficiency Clinical Trials Market Analysis
This report presents a strategic analysis of the Singapore Growth Hormone Deficiency Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Growth Hormone Deficiency Clinical Trials Market, offering unmatched value, accuracy and expert insights.
Singapore COVID-19 Clinical Trials Market Analysis
This report presents a strategic analysis of the Singapore COVID-19 Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Singapore COVID-19 Clinical Trials Market, offering unmatched value, accuracy, and expert insights.
Singapore Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Analysis
This report presents a strategic analysis of the Singapore Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market, offering unmatched value, accuracy and expert insights.
Singapore Clinical Trials Support Service Market Analysis
This report presents a strategic analysis of the Singapore Clinical Trials Support Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Clinical Trials Support Service Market, offering unmatched value, accuracy and expert insights.
Singapore Liver Disease Drugs Market Analysis
This report presents a strategic analysis of the Singapore Liver Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Liver Disease Drugs Market, offering unmatched value, accuracy and expert insights.
Singapore Over The Counter (OTC) Analgesics Market Analysis
This report presents a strategic analysis of the Singapore Over The Counter (OTC) Analgesics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Over The Counter (OTC) Analgesics Market, offering unmatched value, accuracy and expert insights.
Singapore Orphan Diseases Drugs Market Analysis
This report presents a strategic analysis of the Singapore Orphan Diseases Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Orphan Diseases Drugs Market, offering unmatched value, accuracy and expert insights.
Singapore Electronic Health Records Market Analysis
Singapore's Electronic Health Record (EHR) market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. Singapore's EHR market growth is due to government initiatives to promote the use of EHR systems and increasing demand for cost-effective and efficient healthcare services. The market is segmented, by application type, and end user. The key market players are MIMS, Allscripts, Cerner, Epic Systems, and others.
Singapore Digital Therapeutics Market Analysis
Singapore Digital Therapeutics Market is at around $7 Mn in 2023 and is projected to reach $38.98 Mn in 2030, exhibiting a CAGR of 27.8 % during the forecast period. The market is being driven by rising chronic disease burden, healthcare infrastructure, and government initiatives and support. The market is dominated by key players like BioMind Labs, DoctorOnCall, FitBit Health Solutions, Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, and Noom Inc.
Singapore Artificial Intelligence (AI) in Healthcare Market Analysis
The Singapore Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.01 Bn in 2022 to $0.17 Bn by 2030, registering a CAGR of 45.82% during the forecast period of 2022 - 2030. The market will be driven by the need for improved efficiency, quality, and accessibility of healthcare services along with Singapore’s thriving startup ecosystem. The market is segmented by healthcare components & by healthcare applications. Some of the major players include NVIDIA, Ping An Healthcare and Technology & CoNEX Healthcare Pte Ltd.
Singapore Biomaterials in Healthcare Market Analysis
Singapore Biomaterials in Healthcare Market is expected to witness growth from $188 Mn in 2022 to $527 Mn in 2030 with a CAGR of 13.80% for the forecasted year 2022-2030. Tissue engineering and other regenerative therapies that depend on biomaterials are becoming more widely known and used in Singapore, which has led to an expansion of the country's Biomaterials in the Healthcare market. The market is segmented by type and by application. Some key players in this market include Biosensors International, Everlife, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
Singapore Medical Devices Market Analysis
This report presents a strategic analysis of the Singapore Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Medical Devices Market, offering unmatched value, accuracy and expert insights.
Singapore Dermatological Therapeutics Market Analysis
Singapore Dermatological Therapeutics Market is at around $0.05 Bn in 2023 and is projected to reach $0.09 Bn in 2030, exhibiting a CAGR of 9.2% during the forecast period. The market is expanding as a result of the prevalence of skin conditions, rising awareness, and consumer preferences for aesthetic procedures. The market is dominated by key players like Almirall SA, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.